Surface IgG (sA20-Ig) of A20
Surface IgG (sA20-Ig) of A20 (106-114) is a specialized peptide construct derived from the immunoglobulin G (IgG) region associated with the A20 protein, specifically encompassing residues 106 to 114. As a synthetic peptide segment, it serves as a valuable molecular tool for probing the structure, function, and interactions of the A20 protein, a well-characterized ubiquitin-editing enzyme involved in the regulation of inflammatory signaling pathways and immune responses. The unique sequence and surface-exposed nature of this peptide make it particularly relevant for studies focused on protein-protein interactions, epitope mapping, and the mechanistic dissection of immune signaling cascades. Its biochemical properties enable researchers to investigate the molecular determinants of A20 function and its modulation in various cellular contexts.
Epitope mapping: Researchers utilize the sA20-Ig (106-114) peptide in epitope mapping studies to identify and characterize antibody binding sites within the A20 protein. By presenting this defined peptide segment in immunoassays, investigators can delineate the specific residues recognized by monoclonal or polyclonal antibodies, facilitating the development of highly selective immunoreagents. This approach supports the generation of custom antibodies for research applications, as well as the validation of antibody specificity in biochemical assays.
Protein-protein interaction analysis: The peptide is frequently employed in in vitro binding assays to explore the interactions between the A20 protein and its molecular partners. Its defined sequence allows for the systematic evaluation of binding affinities and the identification of critical contact points involved in signal transduction pathways. By using this segment as a probe or competitor, scientists can dissect the molecular mechanisms underlying A20-mediated regulation of immune signaling, providing insights into the modulation of NF-κB and related pathways.
Peptide-based assay development: The defined structure and immunogenic properties of this peptide make it an ideal standard for the development and optimization of peptide-based assays, such as ELISA or surface plasmon resonance (SPR) studies. Incorporation of the sA20-Ig (106-114) segment into assay platforms enables the quantitative measurement of antibody responses, the screening of peptide inhibitors, or the assessment of binding kinetics. This supports both fundamental research and high-throughput screening efforts in immunology and cell signaling.
Functional studies of post-translational modification: Given the regulatory role of A20 in ubiquitination and deubiquitination processes, the peptide serves as a model substrate for investigating post-translational modifications that may occur within the 106-114 region. By subjecting the peptide to enzymatic modification in vitro, researchers can analyze the effects of phosphorylation, ubiquitination, or other covalent changes, thereby elucidating how these modifications influence A20 activity and downstream signaling events.
Structural biology and computational modeling: The precise sequence and surface accessibility of the sA20-Ig (106-114) peptide render it a valuable template for structural and computational studies. It can be employed in crystallographic or NMR analyses to determine conformational features, or incorporated into molecular dynamics simulations to predict interaction interfaces and flexibility. Such investigations contribute to a detailed understanding of A20 protein architecture and inform the rational design of modulators targeting this critical immune regulator.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More